Functional Neuroradiology Principles and Clinical Applications 2nd Edition Scott H. Faro PDF Download
Functional Neuroradiology Principles and Clinical Applications 2nd Edition Scott H. Faro PDF Download
https://ebookmeta.com/product/functional-neuroradiology-
principles-and-clinical-applications-2nd-edition-scott-h-faro/
https://ebookmeta.com/product/niedermeyer-s-
electroencephalography-basic-principles-clinical-applications-
and-related-fields-donald-l-schomer-fernando-h-lopes-da-silva/
https://ebookmeta.com/product/functional-analysis-fundamentals-
and-applications-2nd-edition-michel-willem/
https://ebookmeta.com/product/clinical-functional-mri-
presurgical-functional-neuroimaging-3rd-edition/
https://ebookmeta.com/product/the-21st-century-voice-
contemporary-and-traditional-extra-normal-voice-2nd-edition-
michael-edward-edgerton/
Fundamentals of Pathology Medical Course and Step 1
Review 2021 Edition Edition Sattar Husain A.
https://ebookmeta.com/product/fundamentals-of-pathology-medical-
course-and-step-1-review-2021-edition-edition-sattar-husain-a/
https://ebookmeta.com/product/caleb-jones-blog-writings-1st-
edition-dream-hunter/
https://ebookmeta.com/product/tell-me-what-really-happened-1st-
edition-chelsea-sedoti/
https://ebookmeta.com/product/beauty-and-the-bin-1st-edition-
joanne-o-connell-o-connell-joanne/
Incubus 2 1st Edition Brandon Varnell
https://ebookmeta.com/product/incubus-2-1st-edition-brandon-
varnell/
Scott H. Faro
Feroze B. Mohamed
Editors
Functional
Neuroradiology
Principles and Clinical Applications
Second Edition
123
Functional Neuroradiology
Scott H. Faro • Feroze B. Mohamed
Editors
Functional Neuroradiology
Principles and Clinical Applications
Second Edition
Editors
Scott H. Faro Feroze B. Mohamed
Division of Neuroradiology Department of Radiology
Thomas Jefferson University Thomas Jefferson University
Philadelphia, PA, USA Philadelphia, PA, USA
This Springer imprint is published by the registered company Springer Nature Switzerland AG
The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
Preface
A decade has passed since the publication of the first edition of this textbook. During the last
several years, there have been several exciting advances in the field of functional neuroradiol-
ogy and its translation into clinical applications. The relatively new leading neuroradiological
medical society, the American Society of Functional Neuroradiology, has also seen tremen-
dous growth during this period, including a new generation of enthusiastic physicians and MR
physicists working together with the goal of further advancing the role of neuroimaging in
clinical decision making. The field of functional neuroradiology is bright. This second edition
expands upon the core topics covered in the first edition etc.
The new topics include:
It is again our hope that this second edition will be a major reference for physicians from
various disciplines, MR physicists, and cognitive neuroscientists in this important growing
field of functional neuroradiology.
v
Acknowledgments
Our second edition, two volume text, includes updates to the chapters from the first edition as
well as 18 new chapters on advanced functional neuroradiology. I would like to wholeheart-
edly thank all of our 100+ authors who have dedicated all of their precious time to contribute
to our book. These are challenging times for many reasons; however all of these dedicated
colleagues continue to pursue their passion for research and education that will guide and
motivate the next generation of physicians and scientists. Again, I want to acknowledge my
family and all of my colleagues at Jefferson who give me the time and encouragement to pur-
sue my academic interests. This importantly includes my friend and colleague Dr. Feroze
Mohamed as we near our 30 years of collaboration with no end in sight. Last, I would like to
thank Springer Publishing and specifically Maureen Pierce, Margaret Moore, and Arulronika
Pathinathan at Springer for their tremendous help in the preparation of this textbook.
Scott H. Faro
vii
Contents
1
Physical Principles of Diffusion Imaging��������������������������������������������������������������� 3
Thinesh Sivapatham and Elias R. Melhem
2 Physical Principles of Dynamic Contrast-Enhanced
and Dynamic Susceptibility Contrast MRI ����������������������������������������������������������� 15
Mark S. Shiroishi, Jerrold L. Boxerman, C. Chad Quarles, Daniel S. R. Stahl,
Saulo Lacerda, Naira Muradyan, Timothy P. L. Roberts, and Meng Law
3 Physical Principles of Non-gadolinium Perfusion Technique
(Arterial Spin Labeling)������������������������������������������������������������������������������������������� 35
Youngkyoo Jung, Huan Tan, and Jonathan H. Burdette
9
Magnetic Resonance Spectroscopy: Physical Principles��������������������������������������� 223
Stefan Blüml
10
Magnetic Resonance Spectroscopy: Clinical Applications����������������������������������� 241
Alena Horská, Adam Berrington, Peter B. Barker, and Ivan Tkáč
11
Chemical Exchange Saturation Transfer (CEST) Imaging ��������������������������������� 293
Daniel Paech and Lisa Loi
ix
x Contents
12 Functional
Imaging-Based Diagnostic Strategy: Intra-axial
Brain Masses������������������������������������������������������������������������������������������������������������� 311
Arastoo Vossough and Seyed Ali Nabavizadeh
13 Functional
Neuroimaging of Epilepsy��������������������������������������������������������������������� 345
Noriko Salamon
14 Functional
Neuroradiology of Traumatic Brain Injury ��������������������������������������� 355
Giacomo Boffa, Eytan Raz, and Matilde Inglese
15 Functional
Neuroradiology of Multiple Sclerosis:
Non-BOLD Techniques��������������������������������������������������������������������������������������������� 373
Francesca Benedetta Pizzini and Giacomo Talenti
16 Functional
Neuroradiology of Psychiatric Diseases����������������������������������������������� 393
Paolo Nucifora
17 Neuroimaging of Pain����������������������������������������������������������������������������������������������� 407
Richard H. Gracely and Pia C. Sundgren
18 Quantitative
and Physiological Magnetic Resonance
Imaging in Glioma ��������������������������������������������������������������������������������������������������� 433
Shah Islam, Melanie A. Morrison, and Adam D. Waldman
19 Principles
of BOLD Functional MRI ��������������������������������������������������������������������� 461
Seong-Gi Kim and Peter A. Bandettini
20 fMRI Scanning Methods ����������������������������������������������������������������������������������������� 473
Chris J. Conklin and Devon M. Middleton
21 Experimental
Design and Data Analysis for fMRI ����������������������������������������������� 485
Geoffrey K. Aguirre
22 Challenges
in fMRI and Its Limitations����������������������������������������������������������������� 497
R. Todd Constable
23 Neurovascular
Uncoupling in Functional MRI����������������������������������������������������� 511
Jorn Fierstra and David J. Mikulis
24 Functional
Connectivity MR Imaging ������������������������������������������������������������������� 521
Corey Horien, Xilin Shen, Dustin Scheinost, R. Todd Constable,
and Michelle Hampson
25 Clinical
Challenges of Functional MRI������������������������������������������������������������������ 543
Nader Pouratian, Bayard Wilson, and Susan Y. Bookheimer
26 fMRI
of Language Systems: Methods and Applications��������������������������������������� 565
Jeffrey R. Binder
27 Functional
MRI of Language and Memory in Surgical Epilepsy:
fMRI Wada Test ������������������������������������������������������������������������������������������������������� 593
Brenna C. McDonald, Rupa Radhakrishnan, and Kathleen M. Kingery
Contents xi
28
Resting State Functional Magnetic Resonance Imaging��������������������������������������� 623
Daniel Ryan, Sachin K. Gujar, and Haris I. Sair
29
fMRI of Human Visual Pathways��������������������������������������������������������������������������� 641
Edgar A. DeYoe, John L. Ulmer, Wade M. Mueller, Lotfi Hacein-Bey,
Viktor Szeder, Mary Jo Maciejewski, Karen Medler, Danielle Reitsma,
and Jedediah Mathis
30 Functional MRI Studies of Memory in Aging, Mild Cognitive
Impairment, and Alzheimer’s Disease ������������������������������������������������������������������� 671
Jian Zhu, Shannon L. Risacher, Heather A. Wishart,
and Andrew J. Saykin
31
Brain Mapping for Cognitive Neuroscience and Neurosurgery��������������������������� 713
Joy Hirsch
32
fMRI of the Central Auditory System��������������������������������������������������������������������� 745
Deborah Ann Hall and Thomas M. Talavage
33 fMRI of Epilepsy������������������������������������������������������������������������������������������������������� 765
Karsten Krakow
34
Functional MRI of Multiple Sclerosis��������������������������������������������������������������������� 781
Heather A. Wishart
35
Applications of fMRI to Psychiatry������������������������������������������������������������������������� 799
Chandni Sheth, Erin C. McGlade, and Deborah Yurgelun-Todd
36
Applications of fMRI to Neurodegenerative Disease��������������������������������������������� 819
Shamseldeen Y. Mahmoud, Moon Doksu, Jonathan K. Lee,
and Stephen E. Jones
37
Applications of MRI to Psychopharmacology������������������������������������������������������� 861
Dan J. Stein, Yihong Yang, and Betty Jo Salmeron
38
Functional MRI: Cognitive Neuroscience Applications ��������������������������������������� 877
Andrew S. Kayser, Anthony J. W. Chen, and Mark D’Esposito
39
Diffusion Tensor Magnetic Resonance Imaging – Physical Principles���������������� 903
Jose Guerrero, Thomas A. Gallagher, Andrew L. Alexander,
and Aaron S. Field
40
Advanced Diffusion Imaging in Neuroradiology��������������������������������������������������� 933
Devon M. Middleton and Chris J. Conklin
41
Diffusion Tractography in Neurosurgical Planning: Overview of Advanced Clinical
Applications��������������������������������������������������������������������������������������������������������������� 951
Jingya Miao, Solomon Feuerwerker, Karim Hafazalla, Lauren Janczewski,
Michael P. Baldassari, Steven Lange, Arichena Manmatharayan,
Jennifer Muller, Michael Kogan, Caio M. Matias, Nikolaos Mouchtouris,
Daniel Franco, Joshua E. Heller, James S. Harrop, Ashwini Sharan,
and Mahdi Alizadeh
xii Contents
42 Issues
in Translating Imaging Technology and Presurgical
Diffusion Tensor Imaging����������������������������������������������������������������������������������������� 969
John L. Ulmer, Jeffrey I. Berman, Wade M. Mueller, Wolfgang Gaggl,
Edgar A. DeYoe, and Andrew P. Klein
43 Clinical
Applications of Diffusion MRI in Epilepsy����������������������������������������������� 1003
Joanne M. Rispoli, Christopher P. Hess, and Timothy M. Shepherd
44 fMRI
and DTI: Review of Complementary Techniques��������������������������������������� 1025
Shruti Agarwal, Hussain Al Khalifah, Domenico Zaca, and Jay J. Pillai
45 DTI:
Functional Anatomy of Key Tracts ��������������������������������������������������������������� 1061
Arash Kamali, Vinodh A. Kumar, Khader M. Hasan, Mohit Maheshwari,
Andrew P. Klein, Kiran Shankar Talekar, John L. Ulmer, and Scott H. Faro
46 Pediatric Applications of fMRI ������������������������������������������������������������������������������� 1085
Byron Bernal and Nolan R. Altman
47 Magnetoencephalography:
Epilepsy and Brain Mapping ����������������������������������� 1123
Erin Simon Schwartz and Timothy P. L. Roberts
48 PET-CT/MR
Imaging in Head and Neck Cancer: Physiologic
Variations, Pitfalls, and Directed Applications������������������������������������������������������� 1137
Laurie A. Loevner
49 Simultaneous
PET and MR Imaging of the Human Brain����������������������������������� 1165
Ciprian Catana, Christin Sander, A. Gregory Sorensen, and Bruce R. Rosen
50 Functional
Imaging in Autism Spectrum Disorder����������������������������������������������� 1205
Junko Matsuzaki, Heather Green, and Timothy P. L. Roberts
51 The
Role of Molecular Imaging in Personalized Medicine����������������������������������� 1223
Michelle Bradbury
52 Quantitative
Metabolic Magnetic Resonance Imaging:
A Case for Bioscales in Medicine����������������������������������������������������������������������������� 1239
Keith R. Thulborn
53 Magnetic Resonance Fingerprinting����������������������������������������������������������������������� 1259
Chaitra Badve and Dan Ma
54 Neuroimaging
of Brain Tumors in the Era of Radiogenomics����������������������������� 1275
Prem P. Batchala, Thomas J. Eluvathingal Muttikkal, Joseph H. Donahue,
M. Beatriz Lopes, Eli S. Williams, Nicholas J. Tustison, and Sohil H. Patel
55 Radiomics
and Radiogenomics in Glioma ������������������������������������������������������������� 1313
Murat Ak and Rivka R. Colen
56 Quantitative T1ρ MR Imaging in Neuroradiology ����������������������������������������������� 1323
Christopher G. Filippi, Alexander Klebba, Scott Hipko, and Richard Watts
Contents xiii
xv
xvi Contributors
Byron Bernal, MD, PPI Brain Institute—Radiology Department, Nicklaus Children’s Health
System, Miami, FL, USA
Adam Berrington, MSCi, DPhil Sir Peter Mansfield Imaging Centre, School of Physics and
Astronomy, University of Nottingham, Nottingham, UK
Jeffrey R. Binder, MD Neurology and Biophysics, Department of Neurology, Medical
College of Wisconsin, Milwaukee, WI, USA
Ari M. Blitz, MD Division of Neuroradiology, Department of Radiology, University
Hospitals, Case Western Reserve University School of Medicine, Cleveland, OH, USA
Cleveland Medical Center, Cleveland, OH, USA
Stefan Blüml, PhD Department of Radiology and Viterbi School of Engineering, Children’s
Hospital Los Angeles/University of Southern California (USC), Los Angeles, CA, USA
Giacomo Boffa, MD Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics,
Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy
Susan Y. Bookheimer, PhD Department of Psychiatry and Behavioral Sciences, Center for
Autism Research and Treatment, University of California, Los Angeles, Los Angeles, CA,
USA
Jerrold L. Boxerman, MD, PhD, FACR Diagnostic Imaging, Warren Alpert Medical School
of Brown University, Providence, RI, USA
Department of Diagnostic Imaging, Rhode Island Hospital, Providence, RI, USA
Michelle Bradbury, MD, PhD MSK-Cornell Center for Translation of Cancer Nanomedicines,
Intraoperative Imaging Program, Department of Radiology and Molecular Pharmacology
Program, Gerstner Sloan Kettering Graduate School of Biomedical Sciences, Memorial Sloan
Kettering Cancer Center & Weill Medical College of Cornell University, New York, NY, USA
Jonathan H. Burdette, MD Department of Radiology, Wake Forest University School of
Medicine, Winston-Salem, NC, USA
Ciprian Catana, MD, PhD Department of Radiology, Athinoula A. Martinos Center for
Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School,
Charlestown, MA, USA
Anthony J. W. Chen, MD Division of Neurology, Department of Veterans Affairs, Northern
California Health Care System, Martinez, CA, USA
Kevin Chen, PhD Department of Radiology, Stanford University, Stanford, CA, USA
Rivka R. Colen, MD Department of Radiology, UPMC Hillman Cancer Center, Pittsburgh,
PA, USA
Chris J. Conklin, PhD Neuroscience Medical Affairs, Bioclinica, Princeton, NJ, USA
R. Todd Constable, PhD Department of Diagnostic Radiology and Biomedical Imaging,
Biomedical Engineering, and Neurosurgery, Interdepartmental Neuroscience Program, Yale
University School of Medicine, New Haven, CT, USA
MRI Research, Yale MRRC, Yale University School of Medicine, New Haven, CT, USA
Interdepartmental Neuroscience Program, Department of Diagnostic Radiology and
Biomedical Imaging, Biomedical Engineering, and Neurosurgery, Yale University School of
Medicine, New Haven, CT, USA
Rachelle Crescenzi, PhD Department of Radiology and Radiological Sciences, Vanderbilt
University Medical Center, Nashville, TN, USA
Contributors xvii
Scott Hipko, BSc Department of Radiology, Robert Larner School of Medicine University of
Vermont, Burlington, VT, USA
Joy Hirsch, PhD Psychiatry, Comparative Medicine, and Neuroscience, Brain Function
Laboratory, Interdepartmental Neuroscience Program, Yale School of Medicine, New Haven,
CT, USA
Haskins Laboratories, New Haven, CT, USA
Neuroscience, Department of Medical Physics and Biomedical Engineering, Faculty of
Engineering Sciences ex officio, University College London, London, UK
Corey Horien, BA, M.Phil Department of Radiology and Biomedical Imaging, Yale
University School of Medicine, New Haven, CT, USA
Alena Horská, PhD Division of Construction and Instruments, National Institutes of Health,
Office of Research Infrastructure Programs, Bethesda, MD, USA
Matilde Inglese, MD, PhD Department of Neuroscience, Rehabilitation, Ophthalmology,
Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, San Martino Polyclinic
Hospital, Genoa, Italy
Shah Islam, MBBS, BSc, FRCR Department of Surgery and Cancer, Imperial College
London, London, UK
Rajan Jain, MD Department of Radiology, New York University Grossman School of
Medicine, New York, NY, USA
Department of Neurosurgery, New York University Grossman School of Medicine, New York,
NY, USA
Lauren Janczewski, MD Department of General Surgery, Northwestern Memorial Hospital,
Chicago, IL, USA
Stephen E. Jones, MD, PhD Division of Neuroradiology, Imaging Institute, Cleveland
Clinic, Cleveland, OH, USA
Youngkyoo Jung, PhD Department of Radiology, University of California, Davis,
Sacramento, CA, USA
Arash Kamali, MD Department of Radiology, University of Texas, Houston, Memorial
Hermann Hospital at Houston Medical Center, Houston, TX, USA
Mohammad I. Kawas, MD Department of Neuroscience, Wake Forest School of Medicine,
Winston-Salem, NC, USA
Andrew S. Kayser, MD, PhD Department of Neurology, University of California at San
Francisco, San Francisco, CA, USA
Division of Neurology, Department of Veterans Affairs, Northern California Health Care
System, Martinez, CA, USA
Helen Wills Neuroscience Institute, University of California at Berkeley, Berkeley, CA, USA
Majid Khan, MD Department of Radiology, Thomas Jefferson University, Philadelphia, PA,
USA
Seong-Gi Kim, PhD Center for Neuroscience Imaging Research/Department of Biomedical
Engineering, Institute for Basic Science/Sungkyunkwan University, Suwon, Korea
Kathleen M. Kingery, PhD Department of Neurology, Indiana University School of
Medicine, Indianapolis, IN, USA
Alexander Klebba, MD Department of Radiology, Donald and Barbara Zucker School of
Medicine at Hofstra-Northwell, Hempstead, NY, USA
xx Contributors
Juan Márquez, MD Diagnostic Imaging, Fundacion Valle Del Lili, Cali, Colombia
Jedediah Mathis, BS Department of Neurology, Medical College of Wisconsin, Milwaukee,
WI, USA
Caio M. Matias, MD Department of Neurosurgery, Thomas Jefferson University Hospital,
Philadelphia, PA, USA
Junko Matsuzaki, PhD Department of Radiology, Lurie Family Foundations MEG Imaging
Center, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
Brenna C. McDonald, PsyD, MBA Department of Radiology and Imaging Sciences, Indiana
University School of Medicine, Indianapolis, IN, USA
Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA
Erin C. McGlade, PhD Department of Psychiatry, University of Utah, Salt Lake City, UT,
USA
Colin D. McKnight, MD Department of Radiology and Radiological Sciences, Vanderbilt
University Medical Center, Nashville, TN, USA
Karen Medler Clinical Research Ethics Board, Vancouver Island Health Authority, Victoria,
BC, Canada
Elias R. Melhem, MD, PhD Department of Diagnostic Radiology & Nuclear Medicine,
Neuroradiology, University of Maryland School of Medicine, Baltimore, MD, USA
Jingya Miao, MS Department of Neurosurgery, Thomas Jefferson University, Philadelphia,
PA, USA
Devon M. Middleton, PhD Department of Radiology, Thomas Jefferson University,
Philadelphia, PA, USA
David J. Mikulis, MD Joint Department of Medical Imaging, Toronto Western Hospital,
Toronto, ON, Canada
Timothy R. Miller, MD Department of Diagnostic Radiology & Nuclear Medicine,
Neuroradiology, University of Maryland School of Medicine, Baltimore, MD, USA
Feroze B. Mohamed, PhD, FASFNR Department of Radiology, Thomas Jefferson University,
Philadelphia, PA, USA
Melanie A. Morrison, PhD Department of Radiology and Biomedical Imaging, University
of California San Francisco, San Francisco, CA, USA
Department of Medicine, Imperial College London, London, UK
Nikolaos Mouchtouris, MD Department of Neurosurgery, Thomas Jefferson University
Hospital, Philadelphia, PA, USA
Wade M. Mueller, MD Department of Neurosurgery, Medical College of Wisconsin,
Milwaukee, WI, USA
Jennifer Muller, MSc Department of Neurosurgery, Thomas Jefferson University Hospital,
Philadelphia, PA, USA
Naira Muradyan, PhD U.S. Food and Drug Administration, Center for Devices and
Radiological Health, Silver Spring, MD, USA
Seyed Ali Nabavizadeh, MD Department of Radiology, Division of Neuroradiology,
Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
Ameya P. Nayate, MD Cleveland Medical Center, Cleveland, OH, USA
xxii Contributors
motion of water molecules in a medium that itself consists water, and only the “apparent diffusion coefficient” (ADC)
primarily of water is termed self-diffusion. The path of any can be calculated [7–9]. The average ADC in the brain is
single water molecule is completely random and would be approximately 0.7 × 10-3 mm2/s [10], about four times
impossible to predict, limited only by the boundaries of the smaller than the diffusion coefficient in free water.
container. Einstein was able to prove that the squared dis-
placement of molecules from their starting point could be
described by the equation: iffusion Encoding and the Stejskal-Tanner
D
Equation
r 2 = 6 Dt (1.2)
where <r2> refers to the mean squared displacement of the Shortly after Bloch and Purcell discovered the NMR phe-
molecules from their original location, t is the diffusion time, nomenon [11–13], Hahn reported his findings that the NMR
and D is the diffusion coefficient for the particular substance spin-echo was sensitive to the effects of diffusion [14]. He
being studied. The diffusion coefficient is typically expressed noted that the random thermal motion of the spins would
in units of mm2/s and relates the average displacement of a reduce the amplitude of the observed spin-echo signal as a
molecule over an area to the observation time; higher diffu- result of the dephasing that occurs in the presence of mag-
sion constants infer increased mobility of water molecules. netic field inhomogeneity, which results in local magnetic
The diffusion coefficient of water at body temperature (37 field gradients. Building on these observations, Carr and
°C) is 3 × 10−3 mm2/s. The distribution of squared displace- Purcell proposed NMR sequences using constant gradients
ments of free water molecules is typically a Gaussian (bell- to sensitize the NMR spin-echo to the effects of diffusion,
shaped) function with peak at zero displacement, indicating and developed a mathematical framework to measure the dif-
that most molecules have the same position at the starting fusion coefficient from these sequences [15]. In 1956, Torrey
point and at time t [7, 8]. The probability of molecular dis- modified Bloch’s magnetization equations to include the
placement by a given distance from the starting position is effects of molecular diffusion [16]; the Bloch-Torrey equa-
the same regardless of the direction of measurement, with tions describe how net magnetization depends on several fac-
standard deviation proportional to the diffusion coefficient tors, including longitudinal and transverse magnetization, as
and time measured. well as diffusion.
Diffusion-weighted (DW) magnetic resonance imaging In their seminal paper on the spin-diffusion experiment in
(MRI) utilizes Brownian motion to study the movement of 1965, Stejskal and Tanner described the theory of the pulsed
water in vivo, thereby garnering information about the gradient spin-echo (PGSE), which replaced the steady-state
underlying tissue structure of the brain. DW MRI does not gradients used by Carr and Purcell with short-duration gradi-
measure the diffusion coefficient directly, but rather the ent pulses [17]. This resulted in much improved sensitivity to
effect of the mean displacement of water molecules within diffusion by distinguishing the encoding time (pulse dura-
each three-dimensional (3-D) volume element, or voxel, on tion) and the diffusion time. This also allowed the direct
the nuclear magnetic resonance (NMR) signal. One might measurement of the diffusion function and paved the way for
ask: If the diffusion coefficient of water at body temperature quantitative measurements of the diffusion coefficient. In the
is a constant, then how can we use this information to evalu- presence of a magnetic field, static spins accumulate phase
ate tissue structure? We must remember that in vivo, water shifts according to the equation:
molecules do not freely diffuse as they would in a medium of
Φ ( t ) = γ B0t + ∫ G ( t ) . X ( t ) dt (1.3)
water alone. In tissues, the movement of water occurs largely
in the extracellular space, and their movement is modified by The first term (γB0t) in the equation represents the phase
interactions with cell membranes and macromolecules, i.e., accumulation owing to the static magnetic field, while the
the underlying tissue structure of the brain. Additionally, the second term (∫G(t).X(t)dt) reflects the effect of a magnetic
movement of water molecules in vivo due to diffusion cannot field gradient. The phase accumulation owing to the gradient
be distinguished from the movement of water molecules is proportional to the strength of the field gradient, spatial
from other sources such as active transport, pressure gradi- location of the spin, and the duration of the gradient pulse.
ents, ionic interactions, and changes in membrane permea- In their experiment, Stejskal and Tanner sensitized a
bility. As a result, the overall movement of water molecules standard spin-echo T2-weighted pulse sequence to diffu-
in the brain is reduced as compared to their movement in free sion by adding a pair of diffusion gradients along the same
1 Physical Principles of Diffusion Imaging 5
axis both before and after the 180° refocusing pulse [17]. The effects of signal loss due to diffusion can be explained
The basic idea is to excite the spins with a 90° radiofre- by the Stejskal-Tanner equation:
quency (RF) pulse, encode the spin position with a time- S = S0 exp ( −bD ) (1.4)
constant magnetic field gradient of duration δ, invert the
spin phase with a 180° refocusing pulse, apply a second where S is the signal intensity observed in a given voxel with
magnetic field gradient equal in intensity and duration to a diffusion gradient applied, S0 is the signal intensity of the
the first gradient at a time Δ after the first gradient, and then same voxel in the absence of a diffusion gradient, b is the
acquire the echo at time TE—echo time. The application of diffusion sensitivity factor, and D is the diffusion coefficient.
a linear gradient to a homogeneous magnetic field results in The diffusion sensitivity factor (b) is a function of the
phase shifts of the spins along that axis, which is position strength, duration, and temporal spacing of the diffusion-
dependent; this phase dispersion leads to signal loss. sensitizing gradients, and can be expressed by the following
However, the application of a second gradient equal to the equation:
first in magnitude and duration but opposite in direction can b = γ 2 G 2δ 2 ( ∆ − δ / 3 ) (1.5)
refocus the phase changes. The first gradient is called the
dephasing gradient, while the second is called the rephas- In this equation, γ is the gyromagnetic ratio (the ratio of
ing gradient [18]. magnetic moment to angular moment of a nuclear spin, a
If a spin is stationary between the applications of the two constant), G is the amplitude of the diffusion gradient (usu-
gradient pulses, the net effect of the gradients is zero and the ally measured in milliteslas per meter), δ is the duration of
spin maintains its signal intensity. This explains the rela- the diffusion gradient pulse (measured in milliseconds), and
tively high signal intensity on DWI seen in the setting of Δ the time interval between the dephasing and rephasing gra-
cytotoxic edema, where there is a relative increase in intra- dient pulses (also measured in milliseconds). The diffusion
cellular water content and water molecules are “trapped” sensitivity factor (b) is measured in units of seconds/mm2.
inside the cells (i.e., unable to diffuse freely) and relative Raising the b-value increases the degree of diffusion weight-
decrease in the size of the extracellular compartment [19– ing (i.e., increases the signal loss caused by the diffusion of
25]. For a spin that moves along the axis of the diffusion water molecules along the direction that the gradient was
gradient, phase accumulation due to the two gradients is no applied; Fig. 1.1). The most effective ways to increase diffu-
longer equal so the rephasing is incomplete. As a result, sion sensitivity, as seen in Eq. (1.3), are to increase gradient
intravoxel dephasing occurs and there is a loss of signal amplitude (G) and gradient duration (δ), as these parameters
intensity; the greater the distance the spin moves along the have a quadratic effect on b. Typical b-values in clinical DWI
axis of the gradient, the greater the signal loss [8, 14, 16, 17]. range from 0 to 1500 s/mm2. However, it should be empha-
This explains the relatively low signal intensity seen on DWI sized that higher diffusion weightings increase exponentially
in the normal brain parenchyma, and even lower signal inten- the contrast between tissues with different diffusion coeffi-
sity in the cerebrospinal fluid (CSF) spaces, where water can cients, but at the same time they decrease the overall signal
diffuse the most freely. intensity and signal-to-noise ratio (SNR) [26, 27].
6 T. Sivapatham and E. R. Melhem
and is described as anisotropic [29–33]. The associated dis- b-value and high b-value (commonly 0 s/mm2 and 1000 s/
placement distribution of anisotropic diffusion is not mm2 in clinical practice). The low b-value sequence essen-
Gaussian or spherical, but rather ellipsoid (or even more tially yields a T2-weighted image. The DW image Si (with b
complex if the underlying tissues contain fibers with various = 1000 s/mm2) can then be divided by the T2-weighted
orientations). This anisotropy can be explained by the diffu- image S0 (with b = 0 s/mm2) to remove the T2-weighting
sion tensor model, and is discussed further in the chapter on effects and produce an exponential image, also known as an
diffusion tensor imaging (DTI). attenuation coefficient map, exponential diffusion-weighted
While isotropic diffusion can be seen in the cerebrospinal image, or the attenuation factor map (shown in Fig. 1.3).
fluid (CSF) spaces and in the gray matter of the adult cere- Areas of restricted diffusion on these maps will demonstrate
bral cortex, diffusion in the white matter is primarily aniso- increased signal intensity, similar to DWI.
tropic. Multiple explanations have been suggested for the ADC values can also be calculated by solving for ADC in
mechanisms underlying diffusion anisotropy of white mat- Eq. (1.7):
ter, including the myelin sheath, axonal direction, axonal ADCi = − ln ( Si / S0 ) / b (1.7)
transport, and local susceptibility gradients [34–36]. Myelin
itself does not appear to be necessary for diffusion anisot- where ln is the natural logarithm. Instead of deriving the
ropy, as experiments have shown anisotropic diffusion in the ADC value mathematically, however, the ADC is typically
absence of myelin [37, 38]. A series of experiments in the determined graphically by obtaining two image sets (again,
1990s excluded the effects of susceptibility-induced gradi- low b-value and high b-value image sets) and plotting the
ents, axonal cytoskeleton, and fast-axonal transport as the natural logarithm of Si versus b for the two b-values; the
etiology of anisotropy in white matter [39–41]. Current evi- ADC is then determined from the slope of that line.
dence suggests that the presence of intact cell membranes is Biological tissue can be considered a combination of
the tissue component predominantly responsible for the intra- and extracellular compartments in which the water
anisotropy of molecular diffusion in white matter, while the molecule is in a state of continuous exchange between these
degree of myelination and cellular density serve to modulate two compartments. The observed signal attenuation in the
anisotropy [42]. diffusion experiment therefore depends on the rate of
exchange and the diffusion time. In the limit of slow
exchange, water spins remain within their respective com-
partments during the diffusion time and signal attenuation
Calculating the ADC
follows a bi-exponential behavior. This bi-exponential
behavior is given by the equation:
Since diffusion in the brain is approximated by the ADC
rather than by direct measurement of the diffusion coeffi- S = S0 f1 exp ( −b1ADC1 ) + f 2 exp ( −b2 ADC2 ) (1.8)
cient, Eq. (1.2) might be better represented as:
where f1 and f2 are the volume fractions of water spins within
Si = S0 exp ( −bADCi ) (1.6)
each of the two compartments and f1 + f2 = 1; ADC1 and
where Si is the signal intensity in a given voxel with the ADC2 are the apparent diffusion coefficients in the two
diffusion-sensitization gradient applied along direction i, and compartments.
ADCi is the ADC in the i direction. In an isotropic environ- On the other hand, in the limit of fast exchange with com-
ment, the direction of the gradient pulse is irrelevant, since plete redistribution of water between the two compartments
the ADCi would be identical for all directions i, and a single during the diffusion time, the signal attenuation follows a
(scalar) diffusion gradient application is sufficient to calcu- single exponential behavior given by the equation:
late the ADC. Higher ADC values result in lower signal S / S0 = exp ( −b∗ ADC ) (1.9)
intensity Si in the DWI, while reduced ADC values result in
higher signal intensity. In addition to contrast due to differ- The observed apparent diffusion coefficient for a two-
ences in ADC, the long TE of a DWI pulse sequence makes compartment system includes contributions from both the
it inherently sensitive to T2-contrast as well. T2-prolongation intracellular and extracellular environments and is approxi-
in pathologic tissues can elevate the DWI signal intensity in mated by the equation:
the absence of reduced ADC values [43]. This “T2-shine-
ADC = f1ADC1 + f 2 ADC2 (1.10)
through” effect results in the DWI hyperintensity being less
specific than reduced ADC values on ADC maps in the mea- In most practical situations, the bi-exponential behavior
surement of true restricted diffusion in tissues (Fig. 1.2). of signal attenuation is not observed. Therefore, it is a com-
In order to remove the T2-effects, the diffusion experi- mon practice to fit the DWI data to the single exponential
ment is repeated for each gradient direction with a low decay model.
8 T. Sivapatham and E. R. Melhem
a b
c d
Fig. 1.2 Images from a patient who presented with an acute stroke restricted diffusion, but rather T2-shine-through on DWI. The lesion
demonstrate the T2-shine-through effects of DWI. The FLAIR image marked by the arrowhead in (d), on the contrary, also demonstrates
(d) shows multifocal areas of T2-prolongation in the periventricular and marked signal intensity on the b = 0 and b = 1000 images, but is dark on
deep white matter (arrow and arrowhead). The lesion marked by the the ADC map, indicating that this is an area of restricted diffusion. ADC
arrow in (d) also demonstrates increased signal on the b = 0 (a), b = apparent diffusion coefficient, FLAIR fluid-attenuated inversion recov-
1000 (b), and ADC (c) images, indicating that this is not an area of ery, DWI diffusion-weighted imaging
1 Physical Principles of Diffusion Imaging 9
Isotropic DWI and Trace ADC tant to concomitantly view the ADC map or exponential
image to evaluate for true restricted diffusion.
Diffusion gradient pulses are applied in one direction at a In neonates and young children, the ADC is initially
time, with the resulting DW image giving both directional much higher in rapidly developing gray matter structures
and magnitude information about the ADC. This would be like the thalamus and basal ganglia, and can be more than
sufficient if imaging an isotropic tissue, since the ADC twice as high in the slowly developing white matter regions
would be the same regardless of the direction of the diffusion [44, 45]. This can be attributed to the relatively high water
gradient. When imaging an anisotropic tissue like the white content in the immature brain, with relative paucity of
matter of the brain, however, interpretation of the DWI myelinated neurons. ADC values decrease rapidly over the
would be challenging if only a single gradient direction were first 2 years of brain development, and continue to decrease
probed, due to the variable signal intensity of white matter gradually through childhood, adolescence, and into young
tracts depending on their orientation relative to the direction adulthood [46–52]. Due to the higher ADC values in neo-
of the diffusion gradient. While the diffusion anisotropy dis- nates and infants compared to adults [45–48], it is common
cussed in the previous section can be exploited to image fiber to reduce the diffusion sensitivity factor (b) in this age
tracts in DTI, the directional effects of anisotropy are unde- group to 600 or 700 s/mm , compared to the 1000 s/mm
2 2
sirable in routine clinical DWI. typically used in adults. In the aging but otherwise healthy
In order to overcome the directional influences of the dif- brain, mild increases can be seen in the ADC, particularly
fusion gradient in anisotropic tissues, four separate scalar in white matter [53–58]. Engelter et al. found a significant
image acquisitions are required: one without a diffusion- correlation between the average ADC of white matter and
sensitizing gradient (S0, where b = 0 s/mm2), and three with age, with patients 60 years of age or older having increased
the diffusion gradients applied in three orthogonal directions ADC compared to those under the age of 60; a similar trend
x, y, and z (which will be called Sx, Sy, and Sz). To create an was seen in the average ADC of the thalamus [55]. Chen
image related only to the magnitude of the ADC, the DW et al. found that the average ADC increases by 3% per
images acquired with the gradient pulses applied in three decade after the age of 40 [56]. This has been attributed to
orthogonal planes can be multiplied, and the cube root of that loss of myelinated neurons and structural changes seen
product yields a DW image weighted with diffusion magni- with aging.
tude information alone and directional information removed,
called the “isotropic DWI” (SDWI):
Current DWI Techniques
S DWI = ( S x S y S z )
1/ 3
(1.11)
The movement of water molecules detected by DWI occurs
The ADC derived from application of the gradients in
on a length scale of micrometers that is significantly larger
three orthogonal planes, called the “trace ADC” (simply
than intracellular distances, but much smaller than the milli-
called ADC below), is the average of the ADCs from each of
meter scale of voxel size in typical magnetic resonance (MR)
the planes (Fig. 1.3):
images. The original PGSE T2-weighted sequence described
ADC = ( ADC x + ADC y + ADCz ) / 3 (1.12) by Stejskal and Tanner was sensitive to even minimal bulk
patient motion, which was enough to obscure the much more
The images submitted to the radiologist for interpretation miniscule molecular motion of diffusion. As MRI technol-
in the clinical setting are typically the isotropic DWI and ogy has improved and high-performance gradients have been
trace ADC images. developed, DWI is now typically performed using spin-echo
single-shot echo-planar imaging (SS-EPI) techniques. With
this type of pulse sequence, an entire two-dimensional (2-D)
DWI of the Normal Brain image can be formed from a single RF excitation pulse
(hence the term “single-shot”). Images can be acquired in a
As mentioned previously, the average ADC in the brain is fraction of a second, minimizing artifacts related to patient
approximately 0.7 × 10−3 mm2/s; more specifically, mean dif- motion. Additionally, the SS-EPI technique has a relatively
fusivities in the adult brain range from 0.67 to 0.83 × 10−3 high signal-to-noise ratio (SNR); this is an important advan-
mm2/s in gray matter, and 0.64 to 0.71 × 10−3 mm2/s in white tage in DWI, as high b-value diffusion gradients cause a sig-
matter [10]. Because the ADC values for gray and white mat- nificant loss of signal intensity (see Eq. (1.4)). Using the
ter are so similar, there is essentially no contrast between SS-EPI technique, DW imaging of the brain can typically be
gray and white matter on the ADC map or exponential image. completed in 1–2 min, beneficial in clinical settings where
The subtle gray–white matter contrast that can be seen on the acutely ill and often uncooperative patients (i.e., hyperacute
DWI can be attributed to T2-effects, which makes it impor- stroke patients) are being imaged.
1 Physical Principles of Diffusion Imaging 11
routinely used in brain imaging for the detection of acute 19. Sevick RJ, Kanda F, Mintorovitch J, Arieff AI, Kucharczyk
ischemia, and is now an essential part of the imaging evalua- J, Tsuruda JS, et al. Cytotoxic brain edema: assess-
ment with diffusion- weighted MR imaging. Radiology.
tion of patients with acute stroke. The applications of DWI in 1992;185(3):687–90.
neuroimaging are extensive, and include the evaluation of 20. Ebisu T, Naruse S, Horikawa Y, Ueda S, Tanaka C, Uto M, Umeda
intracranial infections, neoplasms, demyelinating processes, M, Higuchi T. Discrimination between different types of white
and trauma. These will be discussed in the following chapter. matter edema with diffusion-weighted MR imaging. J Magn Reson
Imaging. 1993;3(6):863–8.
DWI techniques can also be used to evaluate the fiber tracts 21. Schaefer PW, Buonanno FS, Gonzalez RG, Schwamm
of the brain, and these techniques and applications are dis- LH. Diffusion-weighted imaging discriminates between cyto-
cussed elsewhere in this book. As MRI technology advances toxic and vasogenic edema in a patient with eclampsia. Stroke.
and improvements are made in imaging hardware and soft- 1997;28:1082–5.
22. Schwartz R, Mulkern R, Gudbjartsson H, Jolesz F. Diffusion-
ware, newer techniques and sequences may provide more weighted MR imaging in hypertensive encephalopathy: clues to
sensitive DW images with reduction in the artifacts inherent pathogenesis. AJNR Am J Neuroradiol. 1998;19:859–62.
in current DWI techniques. 23. Ay H, Buonanno FS, Schaefer PW, Le DA, Wang B, Gonzalez
RG, Koroshetz WJ. Posterior leukoencephalopathy without severe
hypertension: utility of diffusion-weighted MRI. Neurology.
1998;51:1369–76.
References 24. Mukherjee P, McKinstry RC. Reversible posterior leukoencepha-
lopathy syndrome: evaluation with diffusion-tensor MR imaging.
1. Moseley ME, Cohen Y, Mintorovitch J, Chileuitt L, Shimizu H, Radiology. 2001;219:756–65.
Kucharczyk J, et al. Early detection of regional cerebral ischemia 25. Provenzale JM, Petrella JR, Cruz LC Jr, Wong JC, Engelter S,
in cats: comparison of diffusion- and T2-weighted MRI and spec- Barboriak DP. Quantitative assessment of diffusion abnormali-
troscopy. Magn Reson Med. 1990;14:330–46. ties in posterior reversible encephalopathy syndrome. AJNR Am J
2. Chien D, Kwong KK, Gress DR, Buonanno FS, Buxton RB, Rosen Neuroradiol. 2001;22:1455–61.
BR. MR diffusion imaging of cerebral infarction in humans. AJNR 26. Chen PE, Simon JE, Hill MD, Sohn CH, Dickhoff P, Morrish WF,
Am J Neuroradiol. 1992;13:1097–102. et al. Acute ischemic stroke: accuracy of diffusion-weighted MR
3. Warach S, Chien D, Li W, Ronthal M, Edelman RR. Fast magnetic imaging–effects of b value and cerebrospinal fluid suppression.
resonance diffusion-weighted imaging of acute human stroke. Radiology. 2006;238(1):232–9.
Neurology. 1992;42:1717–23. 27. Kim HJ, Choi CG, Lee DH, Lee JH, Kim SJ, Suh DC. High-b-value
4. van Everdingen KJ, van der Grong J, Kappelle LJ, Ramos LM, diffusion-weighted MR imaging of hyperacute ischemic stroke at
Mali WP. Diffusion-weighted magnetic resonance imaging in acute 1.5T. AJNR Am J Neuroradiol. 2005;26(2):208–15.
stroke. Stroke. 1998;29(9):1783–90. 28. Le Bihan D. Looking into the functional architecture of the brain
5. Brown R. A brief account of microscopical observations made in with diffusion MRI. Nat Rev Neurosci. 2003;4(6):469–80.
the months of June, July and August 1827 on the particles contained 29. Cleveland GG, Chang DC, Hazlewood CF, Rorschach HE. Nuclear
in the pollen of plants, and on the general existence of active mol- magnetic resonance measurement of skeletal muscle: anisotropy
ecules in organic and inorganic bodies. Philos Mag. 1828;4:161. of the diffusion coefficient of the intracellular water. Biophys J.
6. Einstein A. Investigations on the theory of Brownian motion. 1976;16(9):1043–53.
New York: Dover; 1956. 30. Moseley ME, Cohen Y, Kucharczyk J, Mintorovitch J, Asgari HS,
7. Jones DK. Studying connections in the living human brain with Wendland MF, Tsuruda J, Norman D. Diffusion-weighted MR
diffusion MRI. Cortex. 2008;44(8):936–52. imaging of anisotropic water diffusion in cat central nervous sys-
8. Hagmann P, Jonasson L, Maeder P, Thiran JP, Wedeen VJ, Meuli tem. Radiology. 1990;176(2):439–45.
R. Understanding diffusion MR imaging techniques: from sca- 31. Moseley ME, Kucharczyk J, Asgari HS, Norman D. Anisotropy in
lar diffusion-weighted imaging to diffusion tensor imaging and diffusion-weighted MRI. Magn Reson Med. 1991;19(2):321–6.
beyond. Radiographics. 2006;26(Suppl 1):205–23. 32. Doran M, Hajnal JV, Van Bruggen N, King MD, Young IR, Bydder
9. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR GM. Normal and abnormal white matter tracts shown by MR imag-
imaging of the brain. Radiology. 2000;217(2):331–45. ing using directional diffusion weighted sequences. J Comput
10. Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di Chiro Assist Tomogr. 1990;14(6):865–73.
G. Diffusion tensor MR imaging of the human brain. Radiology. 33. Chenevert TL, Brunberg JA, Pipe JG. Anisotropic diffusion in
1996;201:637–48. human white matter: demonstration with MR techniques in vivo.
11. Bloch F. Nuclear induction. Phys Rev. 1946;70:460–74. Radiology. 1990;177(2):401–5.
12. Bloch F, Hansen WW, Packard M. Nuclear induction. Phys Rev. 34. Thomsen C, Henriksen O, Ring P. In vivo measurement of water
1946;69:127. self-diffusion in the human brain by magnetic resonance imaging.
13. Purcell EM, Torrey HC, Pound RV. Resonance absorption by Acta Radiol. 1987;28(3):353–61.
nuclear magnetic moments in a solid. Phys Rev. 1946;69:37. 35. Hong X, Dixon WT. Measuring diffusion in inhomogeneous sys-
14. Hahn EL. Spin echoes. Phys Rev. 1950;80:580–94. tems in imaging mode using antisymmetric sensitizing gradients. J
15. Carr HY, Purcell EM. Effects of diffusion on free precession in Magn Reson. 1992;99:561–70.
nuclear magnetic resonance experiments. Phys Rev. 1954;94:630–8. 36. Lian J, Williams DS, Lowe IJ. Magnetic resonance imaging in the
16. Torrey HC. Bloch equations with diffusion terms. Phys Rev. presence of background gradients and imaging of background gra-
1956;104:563–35. dients. J Magn Reson Ser. 1994;106:65–74.
17. Stejskal EO, Tanner JE. Spin diffusion measurements: spin echoes 37. Wimberger DM, Roberts TP, Barkovich AJ, Prayer LM, Moseley
in the presence of a time-dependent field gradient. J Chem Phys. ME, Kucharczyk J. Identification of “premyelination” by diffusion-
1965;42:288–92. weighted MRI. J Comput Assist Tomogr. 1995;19(1):28–33.
18. Mori S, Barker PB. Diffusion magnetic resonance imaging: its prin- 38. Prayer D, Roberts T, Barkovich AJ, Prayer L, Kucharczyk J,
ciple and applications. Anat Rec. 1999;257(3):102–9. Moseley M, Arieff A. Diffusion-weighted MRI of myelina-
1 Physical Principles of Diffusion Imaging 13
tion in the rat brain following treatment with gonadal hormones. 50. Schneider JF, Il’yasov KA, Hennig J, Martin E. Fast quantitative
Neuroradiology. 1997;39(5):320–5. diffusion-tensor imaging of cerebral white matter from the neonatal
39. Beaulieu C, Allen PS. Determinants of anisotropic water diffusion period to adolescence. Neuroradiology. 2004;46(4):258–66.
in nerves. Magn Reson Med. 1994;31(4):394–400. 51. Snook L, Paulson LA, Roy D, Phillips L, Beaulieu C. Diffusion
40. Beaulieu C, Allen PS. Water diffusion in the giant axon of the tensor imaging of neurodevelopment in children and young adults.
squid: implications for diffusion-weighted MRI of the nervous sys- NeuroImage. 2005;26(4):1164–73.
tem. Magn Reson Med. 1994;32(5):579–83. 52. Hermoye L, Saint-Martin C, Cosnard G, Lee SK, Kim J, Nassogne
41. Beaulieu C, Allen PS. An in vitro evaluation of the effects of local MC, Menten R, Clapuyt P, Donohue PK, Hua K, Wakana S, Jiang
magnetic-susceptibility-induced gradients on anisotropic water dif- H, van Zijl PC, Mori S. Pediatric diffusion tensor imaging: normal
fusion in nerve. Magn Reson Med. 1996;36(1):39–44. database and observation of the white matter maturation in early
42. Beaulieu C. The basis of anisotropic water diffusion in the nervous childhood. NeuroImage. 2006;29(2):493–504.
system - a technical review. NMR Biomed. 2002;15(7):435–55. 53. Gideon P, Thomsen C, Henriksen O. Increased self-diffusion of brain
43. Burdette JH, Elster AD, Ricci PE. Acute cerebral infarction: quan- water in normal aging. J Magn Reson Imaging. 1994;4(2):185–8.
tification of spin-density and T2 shine-through phenomena on 54. Chun T, Filippi CG, Zimmerman RD, Uluğ AM. Diffusion
diffusion-weighted MR images. Radiology. 1999;212(2):333–9. changes in the aging human brain. AJNR Am J Neuroradiol.
44. Hüppi PS, Maier SE, Peled S, Zientara GP, Barnes PD, Jolesz FA, 2000;21(6):1078–83.
Volpe JJ. Microstructural development of human newborn cerebral 55. Engelter ST, Provenzale JM, Petrella JR, DeLong DM, MacFall
white matter assessed in vivo by diffusion tensor magnetic reso- JR. The effect of aging on the apparent diffusion coefficient
nance imaging. Pediatr Res. 1998;44(4):584–90. of normal appearing white matter. AJR Am J Roentgenol.
45. Neil JJ, Shiran SI, McKinstry RC, Schefft GL, Snyder AZ, Almli 2000;175:425–30.
CR, Akbudak E, Aronovitz JA, Miller JP, Lee BC, Conturo 56. Chen ZG, Li TQ, Hindmarsh T. Diffusion tensor trace map-
TE. Normal brain in human newborns: apparent diffusion coeffi- ping in normal adult brain using single-shot EPI technique.
cient and diffusion anisotropy measured by using diffusion tensor A methodological study of the aging brain. Acta Radiol.
MR imaging. Radiology. 1998;209(1):57–66. 2001;42(5):447–58.
46. Mukherjee P, Miller JH, Shimony JS, Conturo TE, Lee BC, Almli 57. Nusbaum AO, Tang CY, Buchsbaum MS, Wei TC, Atlas
CR, McKinstry RC. Normal brain maturation during childhood: SW. Regional and global changes in cerebral diffusion with normal
developmental trends characterized with diffusion-tensor MR aging. AJNR Am J Neuroradiol. 2001;22(1):136–42.
imaging. Radiology. 2001;221(2):349–58. 58. Moseley M. Diffusion tensor imaging and aging - a review. NMR
47. Mukherjee P, McKinstry RC. Diffusion tensor imaging and trac- Biomed. 2002;15(7-8):553–60.
tography of human brain development. Neuroimaging Clin N Am. 59. Le Bihan D, Poupon C, Amadon A, Lethimonnier F. Artifacts and pit-
2006;16(1):19–43. falls in diffusion MRI. J Magn Reson Imaging. 2006;24(3):478–88.
48. Mukherjee P, Miller JH, Shimony JS, Philip JV, Nehra D, Snyder AZ, 60. Mukherjee P, Chung SW, Berman JI, Hess CP, Henry RG. Diffusion
Conturo TE, Neil JJ, McKinstry RC. Diffusion-tensor MR imaging tensor MR imaging and fiber tractography: technical consider-
of gray and white matter development during normal human brain ations. AJNR Am J Neuroradiol. 2008;29(5):843–52.
maturation. AJNR Am J Neuroradiol. 2002;23(9):1445–56. 61. Bammer R. Basic principles of diffusion-weighted imaging. Eur J
49. McGraw P, Liang L, Provenzale JM. Evaluation of normal age- Radiol. 2003;45(3):169–84.
related changes in anisotropy during infancy and childhood 62. Mukherjee P, Berman JI, Chung SW, Hess CP, Henry RG. Diffusion
as shown by diffusion tensor imaging. AJR Am J Roentgenol. tensor MR imaging and fiber tractography: theoretic underpinnings.
2002;179(6):1515–22. AJNR Am J Neuroradiol. 2008;29(4):632–41.
Physical Principles of Dynamic
Contrast-Enhanced and Dynamic 2
Susceptibility Contrast MRI
T1-Weighted Dynamic Table 2.2 QIBA DCE-MRI acquisition parameters for brain imaging
Contrast-Enhanced MRI Parameter DCE-MRI
Field strength 1.5/3T
When applied to the brain, DCE-MRI is primarily employed Acquisition sequence 3D SPGR
to characterize the functional integrity of the blood–brain Receive coil type ≥8 channel head array coil
Lipid suppression On
barrier (BBB) via estimation of microvascular permeability
Slice thickness ≤5 mm
to GBCAs. The evaluation of cancer is a major application of Gap thickness 0–1 mm
DCE-MRI where it has potential to provide prognostic, pre- FOV 220–240 mm
dictive, and physiological response imaging biomarkers. Acquisition matrix 256 × 128–160
Conventional GBCAs used in clinical MRI are diffusible, Plane orientation Axial
low-molecular-weight extracellular agents (~500 to 1000 Phase/frequency encode direction AP/RL
Da) that remain intravascular when the BBB is intact. Receiver bandwidth 250 Hz/pixel
Pre-contrast Post-contrast
Disruption of the BBB secondary to a variety of pathological
# Phases ≥5 40–80
processes results in the transfer of GBCA moieties across the
# Averages ≥1 1
capillary endothelium from the intravascular space into the Flip angles 2–30a 25–30
extravascular–extracellular space (EES). Leakage of GBCAs TR (ms) 3–8 msb 3–8
into the EES results in T1-shortening and contrast enhance- TE ≤3 msb ≤3 ms
ment on T1-weighted imaging. Temporal resolution <10 (ideal 5) s
Total acquisition time 5–10 min
3D three dimensional; DCE-MRI dynamic contrast-enhanced magnetic
DCE-MRI Acquisition resonance imaging, FA flip angle, FOV field of view, SPGR spoiled gra-
dient recalled aqcquisition; TE echo time, TR repetition time
Source: Adapted with permission from [5]
There has historically been quite a variation of DCE-MRI a
Variable FAs for T10 measurement
acquisition protocols in the literature. DCE-MRI acquisition b
Ensure that TR/TE stays constant for all FAs
parameters are generally intended to emphasize R1 contrast
and minimize competing T2* effects by employing short with parallel imaging (GRAPPA) along with two-dimensional
echo times (TEs) and repetition times (TRs) [2]. DCE-MRI (2D) or three- dimensional (3D) + simultaneous multislice
most often utilizes a fast T1-weighted spoiled gradient- imaging (SMS) encoding [9], radial k-space encoding with
recalled echo sequence with the temporal resolution contin- golden angle ordering (GRASP) method [10], high under-sam-
gent on the volume coverage, contrast-to-noise ratio (CNR), pling factors, [11] and time-resolved MR angiography methods
and spatial resolution for a particular organ system [4, 5]. with keyhole view-sharing [12].
The temporal resolution demands for DCE-MRI are gener-
ally less than that for DSC-MRI unless an arterial input func-
tion (AIF) is needed [2]. DCE-MRI scan durations are DCE-MRI Data Analysis
generally much longer than for DSC-MRI and to estimate
microvascular permeability with DCE-MRI, the temporal In DCE-MRI, the concentration of GBCA must be deter-
resolution generally ranges between 5 and 20 s [6–8]. Like mined in order to perform pharmacokinetic (PK) modeling.
with DSC-MRI, consistent technique including the use of a This is accomplished by measuring changes in T1-weighted
power injector for bolus injection (2–4 cc/s) of GBCA fol- signal intensity and assuming that these changes are propor-
lowed by a 20–30 cc saline flush at the same rate into the tional to GBCA concentration. This is a commonly used
right arm to decrease possible venous reflux should be per- assumption given its simplicity; however, at high tracer con-
formed if possible in all cases. centrations, the relationship between signal intensity and
Recent initiatives such as those by the Radiological Society GBCA concentration is non-linear and this can result in sys-
of North America’s (RSNA’s) Quantitative Imaging Biomarkers tematic error of DCE-MRI parameters.
Alliance (QIBA) have focused on standardizing acquisition Some studies have utilized predetermined T1 values,
and analysis of various imaging methods including DCE- usually from the literature. However, this too can result in
MRI. QIBA recommendations for DCE-MRI acquisition are bias for several reasons: these are often performed in healthy
included in Table 2.2 [5]. (Please see section “Standardization subjects and there is then no consideration of the effects of
Efforts and Variability of DCE-MRI” below). In addition to aging or pathological conditions nor does it consider indi-
conventional DCE-MRI acquisition methods, there have been vidual variability or tissue heterogeneity [1, 13–18].
several recent advances in pulse sequence acceleration meth- Therefore, direct measurement of T1 in a given individual is
ods to obtain high temporal and/or spatial resolution in DCE- more desirable because of potential T1 variability, particu-
MRI. These include dynamic compressed sensing combined larly from pathological states. The gold standard method of
2 Physical Principles of Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast MRI 17
T1 mapping uses inversion recovery (IR) sequences; how- kinetics of GBCA tissue accumulation [28, 29]. While easier
ever, their long acquisition times preclude routine use [19]. to perform than PK modeling of DCE-MRI data, these semi-
The most commonly employed form of clinical T1 mapping quantitative methods cannot distinguish between physiologic
is the variable flip angle (VFA) method using flip angles factors and physical properties of image acquisition includ-
(FAs) of 2–30° with a gradient echo sequence (Table 2.2) ing, but not limited to, scanner parameters, method of GBCA
[5]. The accuracy of T1 mapping relies on FA accuracy, administration, and native T1 of the interrogated tissue
which can be compromised due to several factors including [30–32].
the presence of standing waves from dielectric resonance in
a subject [20], less uniform FA from smaller transmit coils,
and poor slice profiles from 2D multi-slice imaging [21]. B1 DCE Pharmacokinetic Modeling
mapping can be particularly helpful to correct FA inaccura-
cies, particularly at 3T and over large anatomic coverage [5, Through more sophisticated PK modeling of DCE-MRI
22]. In addition to the IR and VFA methods, the Look- data, various quantitative parameters can be determined: the
Locker (LL) method is another technique for T1 mapping. volume transfer constant between blood plasma and the EES
Like the VFA method, LL methods are faster than IR; how- (Ktrans), the volume of EES per unit volume of tissue (ve), the
ever, they may also result in errors with studies suggesting rate constant between EES and blood plasma (kep, where kep
that VFA may result in overestimation while LL may under- = Ktrans/ve), capillary wall permeability surface area product
estimate T1 values due to inaccurate B1 mapping and per unit volume of tissue (PSρ), and capillary blood flow
incomplete spoiling [19]. (perfusion) per unit volume of tissue (Fρ) [6]. Most DCE-
The determination of the arterial input function (AIF) to MRI tracer kinetic models divide the tissue of interest into
obtain more accurate measurement of the concentration of several compartments (Fig. 2.1). These include the blood
GBCA in blood plasma (Cp(t)) can be another source of error plasma volume per unit volume of tissue (vp) and the volume
in DCE-MRI. Partial-volume average artifacts due to limita- of extravascular–extracellular space per unit volume of tis-
tions in spatial resolution can result from the sampling of a sue (ve).
small cerebral artery. Sampling from a large vein such as the Of the various PK models that have been used to analyze
superior sagittal sinus as a venous outflow function (VOF) DCE-MRI data, the most popular model is commonly
can be used to correct partial-volume average artifacts by referred to as the Tofts model [6, 33] and provides measures
rescaling the area under the AIF curve [23–25]. The use of of Ktrans and ve. Ktrans was originally described by the follow-
three-dimensional (3D) image acquisition, ensuring that the ing equation:
artery of interest is well visualized in the excitation slab, or
dCe ( t )
using non-selective saturation pre-pulse can help alleviate ve = K trans ( C p ( t ) − Ce ( t ) )
inflow artifacts where the arterial blood appears bright on dt
pre-contrast images [26]. If measurement of an individual where Cp and Ce are the blood plasma and EES contrast agent
AIF is not practical, other alternatives that have been used concentrations, respectively (Fig. 2.1). Ktrans is the most fre-
include population-based AIFs that do not incorporate indi- quently utilized metric in DCE-MRI and describes the rate of
vidual differences. There are also reference tissue models contrast agent flux into the EES. Its physiological meaning
that attempt to estimate the vascular tracer concentration
from one or more normal-appearing surrounding tissues
[27]. Hematocrit values should theoretically be incorporated
into the AIF measurement because the GBCA remains in the
blood plasma component and does not pass into red blood
cells. However, in practice, a standard, rather than a directly
measured, hematocrit value is used and this too can result in
errors [4].
There are a variety of methods to analyze DCE-MRI data.
At its most basic, non-PK modeling methods use subjective
assessment of the signal intensity-time curve. These are sim-
ple to perform and interpret, yet will not provide in-depth
understanding of the underlying pathophysiology [28]. Other Fig. 2.1 Schematic of two-compartment model in DCE-MRI. Keys: vp
methods involve semi-quantitative analysis of data with met- = blood plasma volume per unit volume of tissue; ve = volume of extra-
rics such as the initial area under the enhancement curve vascular extracellular space per unit volume of tissue; Ktrans = volume
transfer constant between blood plasma and EES; Cp = tracer concen-
(IAUC) and other methods of signal intensity-time curve tration in arterial blood plasma; Ce = tracer concentration in EES; and
analysis that provide more detailed characterization of the blue circles = intracellular space where contrast agent is excluded
18 M. S. Shiroishi et al.
can be complex as it is dependent on vascular permeability, where vp represents the blood plasma volume per unit vol-
capillary surface area, and the type of contrast agent utilized ume of tissue. This model is often referred to as the “extended
[34]. When there is very high permeability of the endothe- Tofts model” [6] (Fig. 2.1). vp may be ignored in situations
lium with respect to blood flow, (F << PS), Ktrans primarily when the plasma volume or tracer concentration is negligi-
reflects blood flow—(Ktrans = F(1 − Hct)—as this is the main ble; e.g., hypovascular low-enhancing tissues or a few min-
limiting factor of the contrast agent flux; in this case, DCE- utes after the bolus. However, in diseases that are highly
MRI could be seen as “perfusion imaging.” When there is perfused, such as neoplasms, there should be consideration
very low permeability as compared to blood flow (F >> PS), of vp [4] (Fig. 2.2).
Ktrans mainly reflects permeability (Ktrans = PS), and in these There are less commonly utilized PK models besides the
situations DCE-MRI could be referred to as “permeability Tofts and extended Tofts models. While the Tofts models
imaging” [6, 34, 35]. assume a bi-directional exchange of CA between the vascu-
In the original Tofts model, neglecting the contribution of lar space and EES, a simpler assumption of a unidirectional
intravascular tracer to the MRI signal may be appropriate for transport of CA from the vascular to the EES compartment
a diffusible tracer where its distribution volume is large rela- can be formulated. The “Patlak model” [37] utilizes this
tive to blood volume. However, with an extracellular tracer, form and can be expressed as:
this may be problematic as its distribution volume is smaller t
[6, 36]. This assumption may produce erroneous Ktrans esti- Ct ( t ) = v p C p ( t ) + K trans ∫C p (τ ) dτ
mates because intravascular tracer could contribute a signifi- 0
cant proportion of the observed tissue signal. Therefore, in The two-compartment exchange model (2XCM) is a
the presence of an intravascular–extracellular tracer, the more generalized kinetic model than the Tofts and Patlak
model has been modified and expressed as: models. It can be used in mixed perfusion and permeability
t conditions that can allow estimation of PS and F to be calcu-
Ct ( t ) = v p C p ( t ) + K trans ∫C p (τ ) e
− K trans ( t −τ ) / ve
dτ lated [1, 38, 39]. This takes the form of:
0
dC p ( t ) dCe ( t )
vp = F ( Ca − C p ) − K PS ( C p − Ce ) and ve = K PS ( C p − Ce )
dt dt
where Ca represents the AIF and KPS now can be thought of increased concern regarding sources of error during data
as Ktrans without the F versus PS uncertainty. It is important to acquisition and analysis [40, 41].
note that more complex modeling such as this necessitates
a b c
Fig. 2.2 A 52-year-old female with pathology-proven high-grade gli- aspect of the right temporal lobe. (c) Ktrans color map demonstrating a
oma. (a) Axial contrast-enhanced T1-weighted image and (b) axial lesion with high values in the enhancing wall of the tumor
T2-weighted image demonstrate an enhancing tumor in the medial
2 Physical Principles of Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast MRI 19
a b
Loc: -6.963
IM: 12
Series: 2
FOV: 360 mm
TR/TE/FA/NEX: 4.7/1.3/30/4
c VIF d Tissue
45 12
40
10
35
30 8
Measured R1 (S1)
Measured R1 (S1)
25
6
20
15 4
10
2
5
0 0
0 5 10 15 20 25 30 35 40 45 0 2 4 6 8 10 12
NIST Theoretical R 1 (S-1) NIST Theoretical R 1 (S-1)
Fig. 2.3 (a) The QIBA dynamic contrast-enhanced phantom layout Standards and Technology (NIST) theoretical R1 values. (d) R1 values
with 32 spheres, with different concentrations of NiCl2 solutions for for the 24 tissue-mimicking inserts. (Images contributed by Edward
varying T1 relaxation rates (R1). (b) T1-weighted MR image of the Jackson, University of Wisconsin-Madison. Reprinted with permission
phantom showing the 32 spheres and (c) R1 values of the eight-vascular from [5]
input function-mimicking inserts compared with National Institute of
Table 2.3 DSC-MRI acquisition parameters for brain imaging between ΔR2∗(t) and C(t) may not hold true [75] and assump-
Parameter DSC-MRI tion of a quadratic relationship could be assumed to mitigate
Field strength 1.5/3T CBF errors, particularly when estimating the AIF [76].
Acquisition sequence Generally GRE-EPI rather than The area beneath the concentration-time curve is calcu-
SE-EPI lated to derive the CBV map. By applying tracer kinetic
Slice thickness 3–5 mm
modeling for intravascular tracer agents [77–80], CBV can
FOV 200 × 200 mm (range, 200 × 200 to
240 × 240 mm) be obtained by integrating C(t) using the following
Acquisition matrix 128 × 128 (range, 64 × 64 to 256 × relationship:
256) t
GBCA injection rate At least 4 mL/s H f ∫ Ct ( t ) dt
TR 1.0–1.5 s (SE-EPI); minimum (vs “as CBV = t
0
GBCA gadolinium-based contrast agent, GRE-EPI gradient echo-echo where ⊗ represents convolution of Ca(t) and the tissue resi-
planar imaging, FOV field of view, SE-EPI spin echo-echo planar imag-
ing, TE echo time, TR repetition time due function R(t), which represents the amount of contrast
Source: Adapted with permission from [51, 70, 71] agent that remains in the tissue at time t.
The deconvolution of the Ca(t) and Ct(t) is needed to
quantify CBF. Of the various methods available, the most
Like in DCE-MRI, changes in DSC-MRI signal intensity are
commonly used model-independent method is singular value
converted to the tissue concentration of GBCA at time t
decomposition (SVD) [81] that is expressed as:
(C(t)). For DSC-MRI, this relation is noted on a voxel-wise
t j
Ct ( t ) = CBF ⋅ ∫Ca ( t ) R ( t − τ ) dτ ≈ ∆t ∑Ca ( ti ) R ( t j − ti )
basis as:
k S (t ) 0 i =0
C ( t ) ∝ k ⋅ ∆R2∗ ( t ) = − ln
TE S0 where it is assumed that R(t) and Ca(t) remain constant over
small time intervals and that cerebral and arterial concentra-
where k represents a proportionality constant (often set to tions are measured at equally spaced time points. In order
unity as it is not known a priori) that is dependent on tissue for SVD to determine R(t), methods have been devised to
type, field strength, contrast agent, and pulse sequence; decrease errors from the potential delay between the AIF
ΔR2∗(t) represents the change in the T2* relaxation rate at and tissue concentration curves [82] and to avoid physiolog-
time t; TE is the echo time; S(t) represents the signal inten- ically unreasonable results due to noise that lead to unstable
sity at time t; and S0 represents the baseline signal intensity solutions. The most common ways to address these two
before arrival of the GBCA. It is assumed that T1 effects issues are to implement a block-circulant AIF discretization
due to an intact BBB are not significant during DSC-MRI matrix with a truncated SVD regularization approach,
acquisition and that there is a linear relationship between respectively [2].
ΔR2∗(t) and C(t) [74]. However, in lesions such as brain Application of the central volume theorem allows calcu-
tumors, disruption of the BBB is common and necessitates lation of the mean transit time (MTT):
changes in acquisition and post-processing methods in
order to compensate for GBCA leakage effects (discussed CBV
MTT =
below). Furthermore, the assumed linear relationship CBF
2 Physical Principles of Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast MRI 23
Aside from CBV, CBF, and MTT, there are several other agent leakage correction, and AIF considerations [2, 50, 51].
emerging DSC-MRI parameters on the horizon. Newer As a result, most DSC-MRI studies rely on qualitative or
kinetic models can provide estimates of oxygen extraction semi-quantitative measures. Most often, a summary statistic
fraction (OEF) and capillary transit time heterogeneity in the form of “relative” CBV (rCBV) or CBF (rCBF) is
(CTH) that may better relate to the oxygen delivery that often used without definition of the AIF [50]. It should be
could be attained for a given CBF [83]. Traditional determi- noted that in addition to “relative” CBV (or CBF), “rCBV”
nation of oxygen availability in the brain is determined using can also refer to “regional” CBV [99]. It is also common for
CBF and arterial oxygen concentration, but these newer relative CBV to refer to a value that is normalized to “nor-
methods have the potential to highlight perfusion derange- mal” tissue, typically contralateral white matter [100], while
ments in brain tissue that may not be detected with conven- “regional” CBV often refers to absolute quantification of
tional DSC-MRI analysis. As was mentioned previously, the CBV.
use of gradient-echo and spin-echo sequences to provide Scaling metrics such as normalization or standardization
simultaneous estimations of Δ(Delta)R2 and Δ(Delta)R2* are commonly applied to non-quantitative rCBV values in
can provide other parameters including measures of vessel order to compare between subjects and imaging sessions.
size imaging (VSI), microvascular density, mean vessel However, the amount of variability intrinsic to these tech-
diameter [84], and vessel architectural imaging (VAI) niques is unclear [101]. With normalization, the mean value
(Fig. 2.4) [85]. In current practice, these measures are of the voxels within a tumoral ROI is divided by those in a
obtained with tissue sampling and defined by the pathologist. reference ROI, usually that in normal-appearing white mat-
However, validation of these techniques could overcome the ter. Normalization is quite commonly used; however, it can
limitations of sampling error and inability to perform longi- be time consuming and lead to user-dependent subjectivity
tudinal analysis, and may become important with the contin- [102]. On the other hand, when standardization is used, there
ued development of anti-vascular and anti-angiogenic is no need to use a reference ROI because rCBV maps are
therapies [86]. transformed to a standardized intensity scale. In this way, it
can function as an objective technique of converting rCBV
values to a consistent scale and it appears to improve rCBV
Arterial Input Function measurement consistency across patients and time [102].
a b
Signal Intensity
Signal Intensity
Time Time
Fig. 2.5 (a) Schematic of signal intensity-time curve with BBB leak- Schematic of signal intensity-time curve with BBB leakage and domi-
age and dominant T1 leakage effect. T1-related signal enhancement nant T2/T2* effects. T2/T2* effects result in more signal decrease and
results in a less signal decrease and subsequent overshooting of the subsequent undershooting of the baseline (straight line). This will lead
baseline (straight line). This will lead to underestimation of rCBV. (b) to overestimation of rCBV. Reprinted with permission from [50]
The decreased susceptibility differences between the Superparamagnetic contrast agents such as iron oxide
intra- and extravascular compartments due to GBCA leakage nanoparticles are a newer type of contrast agent that may be
result in temporally variant decreases in GBCA T2* relaxiv- advantageous compared to GBCAs given their lack of
ity [25, 103]. More T2* signal decrease can result from extravasation, more prominent T2 and T2* relaxivity, and
mesoscopic magnetic field gradients induced by compart- recent concerns about potential long-term effects of gado-
mentalization of GBCA around cells (Fig. 2.6). These linium tissue deposition [114]. Though there are no current
changes may be influenced by cellular features such as such blood pool agents approved for DSC-MRI, ferumoxytol
shape, size, density, polydispersity, and atypia [104]. The can be used off-label for DSC-MRI [115]. Ferumoxytol is a
potential interaction between T1 and T2/T2* effects in the macromolecular, carbohydrate-coated iron oxide particle
same lesion further complicates interpretation of rCBV val- that has been sold under the name Feraheme as an iron
ues [105]. replacement for adult renal failure patients [116, 117], and
There has historically been various methodologies several studies have shown promise of DSC-MRI using this
employed to address leakage effects including low flip angle agent to distinguish pseudoprogression from tumor progres-
and dual TE acquisitions, preload GBCA dosing, and math- sion in brain tumor patients [118, 119].
ematical post-processing models [105–108]. Current recom-
mendations (see section “Standardization Efforts and
Variability of DSC-MRI” below) to correct for leakage tandardization Efforts and Variability
S
effects in single-echo GRE-EPI sequences are to use 60° FA of DSC-MRI
acquisition with full-dose preload or 30° FA without preload,
both with full-dose bolus GBCA administration and applica- As with DCE-MRI, there has been a lack of standardized
tion of the Boxerman-Schmainda-Weisskoff (BSW) model- methodology for DSC-MRI [120]. Significant variation in
based leakage correction method [51, 70, 109–111]. The rCBV values can result from differences in image acquisi-
BSW model generates rCBV corrected for T1 and T2* leak- tion and post-processing methods, particularly with regard to
age effects by using linear fitting to calculate voxel-wise dif- dealing with leakage effects [121]. This lack of standardiza-
ferences in ΔR2∗ curves from non-enhancing regions and tion has made inclusion of DSC-MRI into clinical trials and
assumes unidirectional GBCA extravasation [105, 112]. routine practice rather difficult, and to help address this, the
Recent work in a rat glioma model suggests that dual-echo American Society of Functional Neuroradiology (ASFNR)
DSC-MRI acquisitions along with a combined biophysical published its recommended DSC-MRI protocol in 2015 cen-
and pharmacokinetic method can potentially eliminate the tered around 1/4–full-dose preload GBCA administration, an
need for preload GBCA dosing [113]. intermediate (60°) flip angle, field strength-dependent TE,
Another Random Scribd Document
with Unrelated Content
CARTA 211
De Santa Teresa a su confesor Fray Jerónimo Gracián, llorando la
muerte del General de los Carmelitas Fray Juan Bautista Rubeo.
Fecha en Ávila a 15 de octubre de 1578.
Jesús.
Sea con vuestra paternidad el Espíritu Santo, mi padre[330]. Como
le veo quitado[331] de esas baraúndas, háseme quitado la pena de lo
demás, venga lo que viniere. Harto grande me la ha dado[332] las
nuevas, que me escriben de nuestro padre general. Ternísima estoy;
y el primer día llorar que llorarás[333], sin poder hacer otra cosa, y
con gran pena de los trabajos que le hemos dado, que cierto no los
merecía; y si hubiéramos ido a él, estuviera todo llano. Dios perdone
a quien siempre lo ha estorbado, que con vuestra paternidad yo me
aviniera, anque, en esto, poco me ha creído. El Señor lo trairá todo a
bien; mas siento lo que digo, y lo que vuestra paternidad ha
padecido; que cierto son tragos de la muerte lo que me escribió en
la carta primera, que dos he recibido después que habló al nuncio.
Sepa, mi padre, que yo me estaba deshaciendo, porque no daba
luego aquellos papeles, sino que debe ser aconsejado de quien le
duele poco lo que vuestra paternidad padece[334]. Huélgome, que
quedará bien experimentado, para llevar los negocios por el camino
que han de ir, y no agua arriba, como yo siempre decía: y a la
verdad ha habido cosas por donde lo impedían todo, y ansí no hay
que tratar de esto, porque ordena Dios cosas para que padezcan sus
siervos.
Ya quisiera escribir más largo, y han de llevar esta noche las
cartas, y casi lo es ya, que lo he sido[335] con el obispo de Osma[336],
para que trate con el presidente y con el padre Mariano lo que le
escribí, y dije enviase a vuestra paternidad. Ahora he estado con mi
hermano[337], y se le encomienda mucho.
NOTAS
[305] Acordarse, construído como recordar con un dativo reflexivo y un
acusativo, es poco usado,
Y como Ovidio escribe en su epistolio,
que no me acuerdo el folio,
estas heridas del amor protervas
no se curan con hierbas.
Lope, Gatom. 2.
[314] Este los se refiere a los libros de caballerías que, aunque hace
mucho se nombraron, no dejan de estar presentes a la memoria en todo
este pasaje. Otra vez vemos aquí la sintaxis de la Santa obedecer más a la
viveza de la imaginación que a la lógica gramatical.
[320] Ante los adverbios más y menos usaban nuestros clásicos las
formas apocopadas muy, tan, cuán («cuán más agradable»), en vez de las
formas plenas mucho, tanto, cuanto, que son hoy de rigor (V. Bello Gram.
§ 1023).
[322] Serna era el mandadero que llevaba las cartas de don Lorenzo.
[333] Frase adverbial, como llora que llora o llora que llorarás, para
denotar la continuidad de la acción.
NOMBRES DE CRISTO
Mas a los que dicen que no leen aquestos mis libros por estar en
romance[341] y que en latín los leyeran, se les responde que les debe
poco su lengua, pues por ella aborrecen lo que, si estuviera en otra,
tuvieran por bueno. Y no sé yo de dónde les nace el estar con ella
tan mal; que ni ella lo merece, ni ellos saben tanto de la latina que
no sepan más de la suya, por poco que della sepan, como de hecho
saben della poquísimo muchos. Y destos son los que dicen que no
hablo en romance, porque no hablo desatadamente y sin orden, y
porque pongo en las palabras concierto y las escojo y les doy su
lugar; porque piensan que hablar romance es hablar como se habla
en el vulgo, y no conocen que el bien hablar no es común, sino
negocio de particular juicio[342], ansí en lo que se dice, como en la
manera como se dice; y negocio que de las palabras que todas
hablan elige las que convienen y mira el sonido dellas, y aun cuenta
a veces las letras, y las pesa y las mide y las compone, para que, no
solamente digan con claridad lo que se pretende decir, sino también
con armonía y dulzura. Y si dicen que no es estilo para los humildes
y simples, entiendan que, así como los simples tienen su gusto, así
los sabios y los graves y los naturalmente compuestos no se aplican
bien a lo que se escribe mal y sin orden; y confiesen que debemos
tener cuenta con ellos, y señaladamente en las escrituras que son
para ellos solos, como aquesta lo es.
Y si acaso dijeren que es novedad, yo confieso que es nuevo, y
camino no usado por los que escriben en esta lengua, poner en ella
número, levantándola del decaimiento ordinario. El cual camino
quise yo abrir[343], no por la presunción que tengo de mí, que sé bien
la pequeñez de mis fuerzas, sino para que los que las tienen se
animen a tratar de aquí adelante su lengua como los sabios y
elocuentes pasados, cuyas obras por tantos siglos viven, trataron las
suyas, y para que la igualen, en esta parte que le falta, con las
lenguas mejores, a las cuales, según mi juicio, vence ella en otras
muchas virtudes.
LIBRO PRIMERO
Dirigiéndose al Obispo de Córdoba, don Pedro Portocarrero,
introduce Fray Luis los personajes que figurarán en el diálogo de
la obra, y supone que son tres amigos suyos, de su misma Orden
de San Agustín.
LA PERFECTA CASADA
LIBRO VII
NOTAS
[338] Véase la nota 343 de la pág. 161.
[339] Algunos de sus párrafos tienen el mismo asunto que sus versos, no
sabiéndose si son su esbozo y plan o su comentario y explicación. (Véase
pág. 169, nota 359, y pág. 170, nota 363.)
[341] Se censuró a Fray Luis por haber escrito en castellano los dos
primeros libros de los Nombres de Cristo, impresos en 1583; pues, aunque
ya habían escrito el P. Avila y el P. Granada, muchos seguían creyendo que
un teólogo no debía emplear para sus obras sino el latín. Fray Luis
contestó reimprimiendo los Nombres de Cristo, en 1585, adicionados con
un tercer libro a cuya introducción pertenece el presente extracto.
[342] Es decir, que no es cosa común a todos los que hablan una lengua,
sino que exige particular disposición y estudio. Es antigua en España la
creencia de que la lengua propia ni merece ni requiere atención y trabajo;
Juan de Valdés se queja de los que con tanta negligencia y tan inmerecido
desdén la tratan, y Ambrosio de Morales, en 1546, decía: «siempre ha
quedado nuestra lengua en la miseria y con la pobreza que antes tenía...
que todo nace del gran menosprecio en que nuestros mismos naturales
tienen nuestra lengua, por lo cual ni se aficionan a ella, ni se aplican a
ayudarla». (Introducción al Diálogo de la dignidad del hombre, del M.
Hernán Pérez de Oliva, tío de Morales.)
[343] Fray Luis, al principio de esta introducción, habla poco menos que
como si él fuera el primero en aplicar el castellano a asuntos serios,
quejándose «de lo mal que usamos de nuestra lengua no la empleando
sino en cosas sin ser». No es admisible que desconociera los autores
citados en la pág. 125, y por fuerza habría leído las obras místicas del
Beato Juan de Ávila y del Venerable Granada, que andaban ya impresas;
sin embargo, a juzgar por las palabras que ahora emplea, parece que no le
satisfacían mucho y no las tomaba en consideración.
[344] A vueltas de significa ‘alrededor de, cerca de’; así fijando después
el día en que esto sucedía, dícese que era el de San Pedro, que es en 29
de Junio, cinco días después de San Juan. En esta frase el artículo se usa
rarísima vez: a las vueltas.
[346] Los nombres de ríos sin artículo, v. pág. 86, n. 161. Los agustinos
calzados, que llegaron a Salamanca por los años 1330, fueron los
fundadores de este convento. Hoy no existe el edificio antiguo, pues fué
bárbaramente destruído por el ejército francés en 1812, y aunque
reedificado, se demolió más tarde, ocupando hoy su solar la nueva calle
llamada de Oliva.—Este monasterio tenía, para descanso y recreo de los
frailes, una granja, llamada la Flecha, a legua y media de distancia, río
arriba, a la vera del camino de Salamanca a Madrid. (V. M. Villar y Macías,
Hist. de Salamanca, I, 453, etc.) La apacible descripción que hace Fray
Luis de este paisaje concuerda en todo con la realidad; tal como él lo
pinta, se reconocen hoy la casa de los frailes, las cuestas que empiezan a
sus espaldas y que si hacia Aldealengua se van insensiblemente
suavizando y disminuyendo, prolónganse larguísimo espacio
eslabonándose hacia Salamanca; todavía existe la desordenada arboleda
que tanto deleitaba la vista del poeta, y la risueña fuente que baja desde
la cuesta al huerto,
y como codiciosa
de ver y acrecentar su hermosura,
hasta llegar, corriendo se apresura.
En fin, el huerto mismo existe, que tanta inspiración guardaba para el
autor de la oda a la Vida retirada y que se llama, como queda dicho,
huerta de la Flecha.
[360] Lanzar, echar pregón o voz se emplean por los simples ‘pregonar’ o
‘vocear’. Compárese la concordancia voz y pregón lanzada con la que
hallamos en la Introducción al Símbolo de la fe (pág. 142) y en el Quijote
(comienzo del extracto de la parte II, capítulo 23).
[362] Para el giro como en cierta manera, véase la nota 358, pág. 168.
Acordarse y recordarse tenían, como se ve aquí, una misma construcción y
régimen (cfr. p. 145, n. 305). Hoy se diferencia mucho, pues se dice
acordar-se de una cosa y recordar una cosa.
[364] Esto es, «en que agradece como un servicio lo que debemos hacer
por nuestro provecho».
[373] Figura dice la edición de Salamanca 1586, pero debe ser errata.
EL P. JUAN DE MARIANA
(1536-1623)
H I S TO R I A D E E S PA Ñ A